ClinicalTrials.Veeva

Menu

Role for Biochemical Assays and Kayser-Fleischer Rings in Diagnosis of Wilson Disease

Zhejiang University logo

Zhejiang University

Status

Enrolling

Conditions

Wilson Disease

Treatments

Dietary Supplement: low copper diet

Study type

Observational

Funder types

Other

Identifiers

NCT04965545
WD-Biochemical assays

Details and patient eligibility

About

The investigators aimed to identify factors associated with symptoms and features of Wilson disease from a large cohort during long-term follow-up

Full description

Wilson disease is an autosomal recessive disorder that impairs copper homeostasis and is caused by homozygous or compound heterozygous mutations in ATP7B, which encodes a copper-transporting P-type ATPase. Patients have variable clinical manifestations and laboratory test results, resulting in diagnostic dilemmas. Therefore, the investigators aimed to identify factors associated with symptoms and features of Wilson disease, thereby give timely diagnosis for patients.

Enrollment

1,000 estimated patients

Sex

All

Ages

6 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • genetically diagnosed patients with wilson disease

Exclusion criteria

  • Deny follow-up

Trial design

1,000 participants in 1 patient group

Wilson's disease cohort
Description:
Patients were clinically diagnosed according to the Leipzig Score and included in the study when they were confirmed to carry ATP7B pathogenic variants in 2 different alleles.
Treatment:
Dietary Supplement: low copper diet

Trial contacts and locations

1

Loading...

Central trial contact

Yi Dong, Ph.D.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems